PHARMAGREEN BIOTECH INC. Research and Development Expense
PHARMAGREEN BIOTECH INC. reported Research and Development Expense of $3.96 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2021-01-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-01-08
- PHARMAGREEN BIOTECH INC. research and development expense for the quarter ending 2019-09-30 was $7.00.
- PHARMAGREEN BIOTECH INC. research and development expense for the quarter ending 2019-06-30 was -$32.66K.
- PHARMAGREEN BIOTECH INC. research and development expense for the quarter ending 2019-03-31 was $6.89K.
- PHARMAGREEN BIOTECH INC. research and development expense for the quarter ending 2018-12-31 was $29.72K.
- PHARMAGREEN BIOTECH INC. research and development expense for fiscal 2019 was $3.96K, a 48.08% decline from fiscal 2018.
- PHARMAGREEN BIOTECH INC. research and development expense for fiscal 2018 was $7.62K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $7.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | -$32.65K derived: sum of 2 quarters · filed 2021-01-08 | -$25.76K derived: sum of 3 quarters · filed 2021-01-08 | $3.96K 10-K · filed 2021-01-08 |
| 2019-06-30 | -$32.66K 10-Q · filed 2020-08-19 | -$25.77K derived: sum of 2 quarters · filed 2020-08-19 | $3.95K 10-Q · filed 2020-08-19 | |
| 2019-03-31 | $6.89K 10-Q · filed 2020-05-19 | $36.60K 10-Q · filed 2020-05-19 | ||
| 2018-12-31 | $29.72K 10-Q · filed 2020-02-18 | |||
| 2018-09-30 | $7.62K 10-K · filed 2019-12-30 |